Notice of Unlawful Sale of Unapproved Drugs to United States Consumers Over the Internet
Similar Posts
Model-Informed Drug Development Paired Meeting Program
FDA is conducting a MIDD Pilot Program to facilitate the development and application of exposure-based, biological, and statistical models derived from preclinical and clinical data sources, referred to as MIDD approaches.Rare Diseases at FDA
The FDA works with many people and groups, such as patients, caregivers, and drug and device manufactures, to support rare disease product development.Executive Order 14017 on America’s Supply Chains
Updates on recommendations to help shore up the U.S. pharmaceutical supply chain, as directed by Executive Order 14017 on America’s Supply ChainsCompounding and the FDA: Questions and Answers
Creating a medication tailored to the needs of an individual patient. FDA answers the “what” and “why” of compounding. From consumers to health care professionals, there are many questions about compounding. FDA works to answer questions related to the meaning, intent and requirements of compoundingFDA-Recognized Antimicrobial Susceptibility Test Interpretive Criteria
FDA-Recognized Antimicrobial Susceptibility Test Interpretive CriteriaPlantBased Innovations Issues Allergy Alert on Undeclared Almond in H-E-B Dairy-Free Coconut Yogurt, Strawberry Flavor
PlantBased Innovations, of Leominster, MA, is recalling Higher Harvest by H-E-B Dairy-Free Coconut Yogurt, Strawberry flavor because the product may contain undeclared almond. People who have an allergy or severe sensitivity to almonds run the risk of serious or life-threatening allergic reaction if